FDA Acquiring ‘Fresh’ Aborted Baby Parts to Make Mice With Human Immune Systems

FDA Acquiring ‘Fresh’ Aborted Baby Parts to Make Mice With Human Immune Systems
The U.S. Food and Drug Administration signed a new contract on July 25 to acquire “fresh” human fetal tissue to transplant into “humanized mice” so that these mice will have a functioning “human immune system,” according to information published by the FDA and the General Services Administration